# Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care

> **NCT06234306** · — · RECRUITING · sponsor: **Copenhagen University Hospital at Herlev** · enrollment: 500 (estimated)

## Conditions studied

- Small Bowel Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06234306
- **Lead sponsor:** Copenhagen University Hospital at Herlev
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2033-12-31
- **Final completion:** 2033-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234306, "Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06234306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*